Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT

Watchlist Manager
Arcturus Therapeutics Holdings Inc Logo
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Watchlist
Price: 6.16 USD -5.23% Market Closed
Market Cap: 175m USD

Wall Street
Price Targets

ARCT Price Targets Summary
Arcturus Therapeutics Holdings Inc

Wall Street analysts forecast ARCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARCT is 32.77 USD with a low forecast of 9.09 USD and a high forecast of 71.4 USD.

Lowest
Price Target
9.09 USD
48% Upside
Average
Price Target
32.77 USD
432% Upside
Highest
Price Target
71.4 USD
1 059% Upside
Arcturus Therapeutics Holdings Inc Competitors:
Price Targets
RPTX
Repare Therapeutics Inc
19% Upside
TWST
Twist Bioscience Corp
19% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
32% Upside
CHRS
Coherus BioSciences Inc
335% Upside
ALEC
Alector Inc
44% Upside
QURE
Uniqure NV
119% Upside
TNG
Transgene SA
53% Upside
CRSP
CRISPR Therapeutics AG
46% Upside

Revenue
Forecast

Revenue Estimate
Arcturus Therapeutics Holdings Inc

The compound annual growth rate of Arcturus Therapeutics Holdings Inc's revenue for the next 4 years is 21%.

N/A
Past Growth
21%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Arcturus Therapeutics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Arcturus Therapeutics Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARCT's stock price target?
Price Target
32.77 USD

According to Wall Street analysts, the average 1-year price target for ARCT is 32.77 USD with a low forecast of 9.09 USD and a high forecast of 71.4 USD.

What is Arcturus Therapeutics Holdings Inc's Revenue forecast?
Projected CAGR
21%

The compound annual growth rate of Arcturus Therapeutics Holdings Inc's revenue for the next 4 years is 21%.

Back to Top